Indian Immunologicals Limited
Indian Immunologicals Limited or IIL is a biopharmaceutical company based in Hyderabad, Telangana, India. IIL is one of the largest vaccine manufacturers in the world.[1] It was established in 1982 by the National Dairy Development Board.[2] [3]
It is noted for developing veterinary and human vaccines for foot-and-mouth disease, rabies, bacterial vaccines, canine vaccines, hepatitis, measles, MMR and DPT.
IIL is a major supplier of DPT, TT and Hepatitis B vaccines to India’s large Universal Immunization Programme.[4][5]
Human Health
IIL operates a manufacturing facility in Ooty to manufacture the Vero cell culture rabies vaccine for use in human beings. This plant was set up in 1998 at the specific request of the Government of India in order to phase out use of the older and unsafe sheep brain vaccine (also termed nerve tissue vaccine – NTV) with the modern tissue culture vaccine.
The plant, which commenced commercial production in phases from September 2006, meets a large part of the requirements of the Universal Immunization Programme of the Ministry of Health, Govt of India.[6]
See also
References
- "Indian Immunologicals Limited".
- "Indian Immunologicals eyes oral vaccine for cervical cancer". The Hindu BusinessLine. Retrieved 29 June 2010.
- "Indian Immunologicals Limited". Internet Archive.
- "Indian Immunologicals to launch 4 vaccines in a year". The Economic Times. Retrieved 30 May 2010.
- "Indian manufacturers account for 60% of vaccine supplies made to UNICEF". BioSpectrum. Retrieved 22 August 2017.
- "Human Biologicals Institute launches Eco Friendly Pack for its Anti Rabies Vaccine 'Abhayrab'". Economic Times HealthWorld.com. Retrieved 8 January 2020.